İbrahim Hızalan
Dr. Hızalan graduated from Istanbul University Cerrahpaşa Faculty of Medicine. In 1980, he spent three months as a visiting physician at Gentofte Hospital (Copenhagen) under the supervision of Prof. Mirko Tos, an experience that strongly influenced his later academic orientation toward otology. He subsequently joined Bursa Uludağ University, where he served on the faculty for 37 years until his retirement.
Throughout his career, Dr. Hızalan has been actively involved in professional organizations at both national and international levels. He was a member of the Steering Committee of the European Academy of Otology and Neurotology (EAONO) and served as President of the Bursa Society of Otorhinolaryngology–Head and Neck Surgery, the Turkish Board of ORL-HNS, and the Balkan Association of ORL-HNS. He has delivered more than 50 instructional courses and invited lectures at international scientific meetings and holds several honorary memberships in professional societies.
His academic work has focused primarily on otology and pediatric otorhinolaryngology, with a particular interest in education and the dissemination of surgical knowledge. Over the years, he has contributed extensively to postgraduate training and international collaboration in the field.
Session
Description
This session highlights the latest research and innovation in ear and hearing science, aligned with the mission of the Mirko Tos Ear & Hearing Research Center. We explore cutting-edge developments, ranging from molecular biomarkers for early diagnosis to minimally invasive surgical techniques. Key topics include novel auditory implants, tinnitus management strategies, and translational research on inner ear pathophysiology. By bringing together audiologists, surgeons, and basic scientists, we aim to accelerate the development of personalized therapies for complex auditory and vestibular disorders.
Outcome Objectives
Upon completion, participants will be able to:
Identify emerging trends in middle ear surgery and hearing rehabilitation technologies.
Evaluate the clinical utility of new diagnostic biomarkers for sensorineural hearing loss and tinnitus.
Apply multidisciplinary, evidence-based strategies to improve patient outcomes in the management of chronic ear disease and vestibular dysfunction.